Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.
暂无分享,去创建一个
K. Farkas | T. Molnár | M. Papp | P. Lakatos | M. Mandel | K. Palatka | Z. Végh | L. Kiss | P. Golovics | B. Lovász | B. Szilágyi | A. Mohás | S. Fekete